Gene Query: DSCAM

Dataset Description Geneva Score
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 108.59
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 53.01
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 42.86
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 39.44
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 39.23
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 39.0
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 36.34
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 34.21
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 34.21
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 33.73
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 33.73
Differential Gene Expression between MCF10A and MCF7 cells 29.17
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 26.15
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 26.15
RNA-seq differential expression studies: more sequence, or more replication? 25.63
snRNAs as regulators of alternative splicing 24.2
IRF2 is a master regulator of human keratinocyte stem cell fate 24.15
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 24.15
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 22.02
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 21.33
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 20.25
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 18.95
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 18.22
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 18.0
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 18.0
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 17.68
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 17.68
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 16.34
Global response to chemotherapy-induced apoptosis 16.0
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 15.97
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 15.92
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 15.92
The transcriptome effect of overexpressing EZH2 in MCF7 15.36
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 15.16
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 14.87
CHCHD2 gene KO effect in iPSC drived motor neurons 14.73
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 13.86
CHCHD10 gene KO effect in iPSC drived motor neurons 13.81
BASP1 modifies the Tamoxifen response 13.35
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 13.21
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 11.67
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.46
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 11.33
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 11.17
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 10.87
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 10.6
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 10.44
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 10.21
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.42
MCF-7 as a model for functional analysis of breast cancer risk variants 9.38
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 9.32
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 8.98
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 8.65
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 8.5
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 8.08
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 8.08
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 7.98
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 7.64
Silencing p300 in MCF7 cells to study expression and alternative splicing 7.64
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 7.43
PTHrP overexpression in MCF7 cells 7.13
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 7.01
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 6.95
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 6.8
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 6.57
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 6.51
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 6.26
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.92
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 5.82
RNA expression following TMPRSS11B overexpression or depletion 5.74
NR2F2 study 5.66
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 5.66
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 5.24
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 5.1
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 5.04
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 4.87
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 4.77
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 4.72
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.7
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.69
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.69
RNAseq of cell lines with knocked in ESR1 mutations 4.62
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 4.54
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 4.54
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 4.43
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.41
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.41
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.4
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.32
Gene expression analysis of breast cancer cell-lines 4.32
Gene expression and genome-wide location analysis of breast cancer cell-lines 4.32
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.11
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 4.05
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 4.05
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.0
RNA-seq analysis of breast cancer 3.97
RNA-seq analysis and shRNA screen of breast cancer 3.97
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 3.95
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.92
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.91
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.89
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.87
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.83
Expression profiling of MCF-7 cells with treatment of TCDD 3.83
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.76
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 3.72
CUREfast: Accelerating research with families 3.71
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 3.54
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 3.54
RNA-Seq analysis of breast cancer cells after shikonin treatment 3.5
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 3.46
Active translatome profiling with RiboLace in MCF7 cells 3.44
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.42
Glioblastoma stem cells infected by ZIKA virus 3.41
Gene expression profile in breast cancer cell lines using RNA sequencing 3.39
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.38
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.38
Transcriptional dependencies in diffuse intrinsic pontine glioma 3.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.32
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 3.28
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 3.2
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 3.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.11
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.09
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 3.08
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 3.04
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 3.03
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.02
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 2.94
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 2.91
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 2.91
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 2.91
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.89
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.87
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.84
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 2.8
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 2.79
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2.78
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.77
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 2.77
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 2.77
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.77
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.76
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.76
EP400 is required for Max and MCPyV mediated gene activation 2.75
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 2.74
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 2.74
RNA sequencing of mechanically strained NHEKs and control NHEKs 2.73
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.68
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 2.66
Examining serotonergic neuron differentiation from human iPSCs 2.63
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 2.61
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.57
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.47
Epigenomic landscape during organ formation in human early embryos 2.4
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.39
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 2.34
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 2.34
Genome wide expression change in LCC2 and MCF-7 cells 2.33
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 2.29
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.29
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.29
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.25
The age and genomic integrity of neurons after cortical stroke in humans 2.22
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.21
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 2.2
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 2.16
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 2.16
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 2.1
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 2.09
The Glioma-Infiltrating T Cell Receptor Repertoire 2.06
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.06
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.06
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 2.06
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 2.06
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 2.0
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 1.99
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.99
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 1.99
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.96
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.94
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.93
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.92
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.88
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.88
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 1.87
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.78
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.75
iPSC derived motor neuron cultures from C9ORF72 carriers 1.68
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.67
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.65
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.64
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 1.62
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.57
circRNA-sequencing 1.54
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.5
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.48
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.48
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 1.47
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 1.45
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.43
Universal alternative splicing of noncoding exons 1.42
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 1.41
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.34
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.34
Disruption of GRIN2B impairs differentiation in human neurons 1.34
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.32
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.3
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 1.3
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 1.3
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.27
Primary human trophoblast from term placenta 1.26
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.25
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 1.22
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.2
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.18
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.16
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.14
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.14
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 1.09
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.08
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.08
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.06
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.06
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.04
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 1.04
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 1.02
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.0
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.98
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.98
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 0.97
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 0.96
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.95
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.95
Human optic chiasm from healthy controls and multiple sclerosis patients 0.93
Multiple sclerosis and EAE 0.93
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 0.92
RNAseq in Alzheimer's Disease patients 0.92
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 0.92
RNAseq of IL-36 stimulated primary human keratinocytes 0.9
Transcriptome analysis of H9 hESC derived cerebral organoids 0.9
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.9
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 0.89
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.88
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.87
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 0.85
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 0.85
Interaction between mitoNEET and NAF-1 in cancer cells 0.84
Dtx3L and Androgen Signaling in Prostate Cancer 0.84
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.83
Hepatosplenic T cell lymphoma 0.83
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.83
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 0.82
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 0.81
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 0.81
BAF controls genome accessibility 0.81
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.8
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.8
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 0.8
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 0.8
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 0.8
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.77
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.76
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.76
Interphase condensins regulate ligand-depedent enhancer activation 0.76
The role of FAM46C in myeloma cells 0.75
The role of FAM46C in myeloma cells [sequencing] 0.75
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 0.74
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 0.73
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.71
FGF2 regulation of gene expression in stable inducible Neurons 0.71
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 0.71
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 0.71
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.7
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.69
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.69
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.67
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 0.67
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 0.67
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.67
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.65
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.64
Repurposing of promoters and enhancers during mammalian evolution 0.63
The circadian transcriptional landscape in primary human mammary epithelial cells 0.63
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.63
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.63
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 0.63
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 0.63
Fbxo32 mediated gene expression program underlies EMT and metastasis 0.62
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.61
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.59
Fusion discovery in breast cancer cell line 0.59
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 0.57
RNA-Seq of the corpus callosum from 12 individuals 0.56
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 0.56
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 0.55
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 0.54
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.53
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.53
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 0.52
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.52
RNA sequencing of BT142 and TS603 cell lines 0.52
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 0.52
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.51
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.51
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 0.51
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.5
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.5
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 0.5
HBEC-shp53-PCHD7 0.5
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 0.49
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.48
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.48
CSL 0.47
CSL RNA-Seq on HKC and SCC cell lines 0.47
Reassessment of Exosome Composition 0.47
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 0.47
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.46
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.46
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.45
The interplay between SOX4 and SMAD3 in the context of breast cancer 0.45
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.45
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 0.44
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.44
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.44
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.44
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 0.42
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.42
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.42
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.41
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.41
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.41
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 0.41
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.41
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.41
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.4
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 0.4
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.4
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.4
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.39
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.39
Transcriptional profiling of microglia; current state of the art and future perspectives 0.39
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.38
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 0.38
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 0.37
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.37
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 0.37
G-quadruplex structures mark human regulatory chromatin 0.37
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.37
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.37
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.36
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 0.36
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.36
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.36
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.36
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.36
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.36
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 0.35
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 0.35
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.35
Gene expression profile in breast cancer cells 0.35
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.35
Dynamic reorganization of nuclear architecture during human cardiogenesis 0.34
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 0.34
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 0.34
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.34
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.34
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 0.34
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 0.32
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 0.32
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 0.31
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 0.31
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.31
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.31
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.31
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.3
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 0.3
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.3
RNA-seq of cells with TET1 knockout 0.3
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.29
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 0.29
Microglia innatly develop within cerebral organoids 0.29
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.29
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 0.28
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.28
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 0.27
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 0.27
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.27
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.27
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.26
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 0.26
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.26
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 0.26
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.26
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.26
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.25
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.25
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.24
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.24
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.24
Induced DNA demethylation, genome instability and transcription 0.24
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.24
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.23
HEK293 Heat-shock experiment 0.23
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 0.23
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.22
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 0.22
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.21
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.21
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 0.21
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 0.21
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 0.21
Global epigenomic reconfiguration during mammalian brain development 0.2
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.2
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 0.2
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.2
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.19
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.19
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.19
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.18
Zika virus directly infects human peripheral neurons and induces cell death 0.18
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 0.17
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 0.17
Engineering Patient-Specific Tissue Implants 0.16
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.16
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.16
Overexpression of NFIB and YBX1 in MCF-7 cells 0.16
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.16
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.16
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.16
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 0.16
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.16
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.16
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.15
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 0.15
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 0.14
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 0.14
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.14
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.14
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.14
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 0.13
NKX2.2 0.13
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.12
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.12
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.11
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.11
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.1
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 0.1
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.1
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.1
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.1
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.1
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.1
Gene expression of thyroid cancer cell lines 0.1
HNF1A deficiency impairs β-cell fate, granule maturation and function 0.1
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 0.09
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.09
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.09
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.09
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.09
Gene expression profile of human placenta from T. Cruzi infected mothers 0.09
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.09
The role of CFTR in islet function 0.09
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.08
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.08
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.07
Energy Metabolism during Anchorage-Independence 0.07
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.07
Identification of expressed and conserved human non-coding RNAs 0.07
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.06
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.06
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.06
Human islets of varying quality: the good, the (not so) bad and the ugly 0.06
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.05
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 0.05
T47D RNA-seq and ChrRNA-seq data 0.05
RNA-seq of SCLC PDX models treated with EP 0.05
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.05
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 0.04
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.04
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.04
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.04
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.04
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.03
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.03
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.03
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 0.03
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.03
RNA-seq in endometrial stromal tumors 0.02
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.02
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.02
Identification of a LIF-responsive replication-competent human β cell 0.02
Activity-dependent transcriptional changes in human neurons 0.01
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.01
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.01
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.01
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.0
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation